This article was provided by a third-party and the opinions expressed here are the author’s. Morningstar values diversity of thought and publishes a broad range of viewpoints. Lithium carbonate fell ...

Rio Tinto’s (ASX.RIO) Pilbara iron ore sales of 72 million metric tons in the second quarter are up 6% on the same quarter of 2025. Primary aluminum production of 840,000 metric tons is flat, but ...

Australia's share market has pared its early losses to end the session roughly flat, as oil prices ease on hopes diplomacy could end a recent re-escalation of the US-Iran conflict. The S&P/ASX200 rose ...

Morningstar Australia provides investment research and ratings for stocks, funds, ETFs and LICs, news and tools for investors and financial professionals.

Last quarter, I covered the most shorted companies on the ASX. At the time, the list was dominated by consumer cyclical and healthcare names. Fast forward to today and the composition has shifted ...

Tivan Ltd is an Australia-based critical minerals company. It is engaged in the exploration, evaluation, and development planning for its resource projects across northern Australia and Timor-Leste.

MSCI has described its mission as enabling investors to build better portfolios for a better world. MSCI’s largest and most profitable segment is its index segment, where it provides benchmarking to ...

In seeking to achieve the investment objective, the Responsible Entity will employ a passive management approach with the aim of tracking the performance of the Index, before fees and expenses. The ...

The Vanguard Index International Shares Fund gains its exposure to securities in the index by investing in the Vanguard International Shares Index Fund (Underlying Fund). The Fund is exposed to all of ...

The Fund will hold or be exposed to most of the securities in the FTSE Australia High Dividend Yield Index allowing for individual security weightings to vary marginally from the Index from time to ...

Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care ...

The fund aims to provide investors with exposure to a portfolio of 20 blue-chip Australian shares (as represented in the S&P/ASX 20 Index), while providing attractive quarterly income that exceeds the ...